These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2971959)

  • 21. Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan.
    Demeilliers B; Jover B; Mimran A
    J Hypertens; 1995 Dec; 13(12 Pt 2):1764-6. PubMed ID: 8903648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ace inhibition in renal disease: risks and benefits.
    Campanacci L; Fabris B; Fischetti F; Bardelli M; Vran F; Carretta R
    Clin Exp Hypertens; 1993; 15 Suppl 1():173-86. PubMed ID: 8513308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ACE-inhibitors in renal protection].
    Barna I
    Orv Hetil; 2006 Jun; 147(22):1019-23. PubMed ID: 16913091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium sensitive hypertension: renal and adrenal non-modulation in its pathogenesis.
    Hollenberg NK; Williams GH
    Kidney; 1988 Nov; 21(3):13-8. PubMed ID: 11538850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects on angiotensin-converting enzyme inhibition on renal hemodynamics in renal artery stenosis.
    Levenson DJ; Dzau VJ
    Kidney Int Suppl; 1987 May; 20():S173-9. PubMed ID: 3037167
    [No Abstract]   [Full Text] [Related]  

  • 26. Angiotensin converting enzyme inhibitors and renal function.
    Mimran A; Ribstein J
    J Hypertens Suppl; 1989 Sep; 7(5):S3-9. PubMed ID: 2681604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Angiotensin converting enzyme inhibitors in renal diseases].
    Shestakova MV; Kutyrina IM
    Kardiologiia; 2002; 42(9):74-9. PubMed ID: 12494080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of angiotensin converting enzyme inhibition in renovascular hypertension.
    Burnier M; Waeber B; Nussberger J; Brunner HR
    J Hypertens Suppl; 1989 Sep; 7(7):S27-31. PubMed ID: 2693654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal perfusion and function. The implications of converting enzyme inhibition.
    Hollenberg NK
    Am J Med; 1988 Apr; 84(4A):9-15. PubMed ID: 3064608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term effects of converting enzyme inhibitors on split renal function in renovascular hypertension.
    Miyamori I; Yasuhara S; Takeda R
    Clin Exp Hypertens A; 1987; 9(2-3):629-32. PubMed ID: 3038426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional testing: renin studies.
    Wilcox CS
    Semin Nephrol; 2000 Sep; 20(5):432-6. PubMed ID: 11022895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Continuous versus intermittent angiotensin converting enzyme inhibition in renal hypertensive rats.
    Battle T; Schnell C; Bunkenburg B; Heudes D; Wood JM; Ménard J
    Hypertension; 1993 Aug; 22(2):188-96. PubMed ID: 8340154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of angiotensin converting enzyme inhibitor and calcium channel blocker on renal function of spontaneously hypertensive rat].
    Endo M
    Nihon Jinzo Gakkai Shi; 1991 Nov; 33(11):1161-72. PubMed ID: 1808367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The renal response to converting enzyme inhibition and the treatment of sodium-sensitive hypertension.
    Hollenberg NK; Williams GH
    Clin Exp Hypertens A; 1987; 9(2-3):531-41. PubMed ID: 3038417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment options for renovascular hypertension.
    Spence JD
    Expert Opin Pharmacother; 2002 Apr; 3(4):411-6. PubMed ID: 11934344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
    J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ischemic nephropathy/azotemic renovascular disease.
    Textor SC; Wilcox CS
    Semin Nephrol; 2000 Sep; 20(5):489-502. PubMed ID: 11022902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blood pressure and renal outcomes in patients with kidney infarction and hypertension.
    Paris B; Bobrie G; Rossignol P; Le Coz S; Chedid A; Plouin PF
    J Hypertens; 2006 Aug; 24(8):1649-54. PubMed ID: 16877969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrasting effects of the renin-angiotensin system on renal function disclosed during converting enzyme inhibition in patients with renal hypertension.
    Rasmussen S; Ibsen H; Giese J
    Scand J Urol Nephrol Suppl; 1984; 79():49-52. PubMed ID: 6089319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.